Your Global partner for Unlicensed Medicine, Shortages and
Reference Listed Drugs (RLD's)
Unlicensed Medicine and Shortages
What Problem does Pro PG solve for the Pharmacy or Health Care Professional?
Patient needs a medicine not commercially available in Australia.
Product is commercially available, however is not clinical suitable for the patient.
Product is in shortage in Australia
Pro PG solves the problem through:
We solve the unmet medical need through global search and sourcing - working directly with Manufacturers, Sponsors or Qualified Licensed Wholesalers. Pro PG supports unmet medical needs for medicines not registered in Australia (or other regions) and we bridge supply gaps addressing market shortages through the S19A or Special Access Scheme (SAS) pathways. Pro PG imports, acts as Sponsor and directly supplies the hospital or institution. Click for More Information.
Reference Listed Drugs (RLD's) and Clinical Trials
One source for all samples worldwide. Single and multiple batch drugs to end pharmaceutical companies and clinical research organisations.
With our appointed Poland based EU GMP manufacturing facility we can provide EU GMP repacking, release and distribution of Clinical Trial supplies into Europe region and secondary labelling requirements for supply to Australia where required. Click for More Information.
Our Unlicensed Medicine customer base
We wholesaler directly with Australian Hospitals, target retail pharmacies and Australian registered compounders e.g. Baxter and Slade Groups. We also supply to NZ Hospitals through Onelink NZ which is owned by EBOS Group.
Current Areas of Business
Supplying Unlicensed Medicine through the Special Access Scheme pathway throughout Australia to meet unmet medical needs of patients.
Supplying alternative products to meet medicine shortages both in Australia and other global regions.
Supplying Reference Listed Drugs (RLD) to our global customer base.
Project Management of Comparator Projects where we are Supplying Comparator products to our EU GMP partner for secondary labelling, release and distribution to European sites.
Distributing and promoting select TGA licensed generic products to our customer base including Hepatitis B product and Oncology Injectables.
Sponsors wanting to consider Australia for Managed Access Programs.
Pro Pharmaceuticals Group partners with sponsors to set up Managed Access Programs (MAP). We can work around the Sponsors needs including offering warehousing, GMP over labelling, Distribution.
MAP allows Hospital / Doctor / Institutions access to pre-approval, investigational drugs outside of the clinical trial setting. Sponsors please contact us for further discussions.
Sandip Manku M.B.A., B.Pharm., MSHP
Sandip Manku is the Managing Director of Pro Pharmaceuticals Group, he is a pharmacist with experience in Australia and the UK, with a Bachelor of Pharmacy from Monash University (1995) and an M.B.A. from Nottingham University Business School U.K (2002). He is a current member of the Society of Hospital Pharmacists Australia (SHPA) and Association of MBA's (AMBA). Sandip was also a former Pharmacy Guild Member and member of the Royal Pharmaceutical Society of Great Britain.
Sandip also has over 20 years experience working in the pharmaceutical industry with roles in both Branded and Generic Pharmaceuticals across a number of companies including Roche, Pfizer, Sanofi, Bayer, Sandoz, Mylan and Dr Reddy's.
Medical Product Advisors
Dr Anita Manku MBBS(Hons), FRACGP (General Medicine)
Dr Rominder Grover BMedSc (Hons) MBBS (Hons) FRACP (Cardiology)
Dr Raaj Chandra MBBS, FRACS, CCSANZ (Colorectal)
Dr Sree Appu MBBS (Hons) Melb, FRACS (Urology)